Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse

Journal of Neuroimmunology

Volumn 245, Issue 1-2, 2012, Pages 32-38

  Chan, K H ^a   Zhang, R ^a   Kwan, J S C ^a   Guo, V Y ^a   Ho, P W L ^a   Ho, J W M ^a   Chu, A C Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aquaporin 4 autoantibodies; Aquaporin 4 water channel; Astrocyte activation; Complement activation; Mouse; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 AUTOANTIBODY; AUTOANTIBODY; FREUND ADJUVANT; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY ISOLATION; ARTICLE; ASTROCYTE; ASYMPTOMATIC DISEASE; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MOUSE; MYELOOPTIC NEUROPATHY; NERVE CELL STIMULATION; NONHUMAN; PARENCHYMA; PATHOGENICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; SCORING SYSTEM;

ANIMALS; AQUAPORIN 4; ASTROCYTES; AUTOANTIBODIES; COMPLEMENT ACTIVATION; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; NEUROMYELITIS OPTICA;

EID: 84859646628     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.02.001     Document Type: Article

References (39)

1. Agarwal R.K., Sun S., Su S., Chan C., et al. Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity. J. Neuroimmunol. 2002, 129:133-140.
2. Ami-Moghaddam M., Ottersen O.P. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 2003, 4:991-1001.
3. Banks W.A. Blood-brain-barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 2005, 11:973-984.
4. Bradl M., Misu T., Takahashi T., Watanabe M., Mader S., et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009, 66:630-643.
5. Chan K.H., Tsang K.L., Fong C.Y., Ho S.L., Cheung R.T.F., Mak W. Idiopathic inflammatory demyelinating disorders after acute transverse myelitis. Eur. J. Neurol. 2006, 13:862-868.
6. Chan K.H., Ramsden D.B., Yu Y.L., Kwok K.H., Chu A.C., Ho P.W., Kwan J.S., Lee R., Lim E., Kung M.H., Ho S.L. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders among Hong Kong Chinese. Eur. J. Neurol. 2009, 16:310-316.
7. Chan K.H., Kwan S.C., Ho W.L., Ho W.M., Chu A.C.Y., Ramsden D.B. Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays. J. Neuroinflammation 2010, 7(1):50.
8. Chan K.H., Kwan J.S.C., Ho P.W.L., Ho S.L., Chui W.H., Chu A.C.Y., Ho J.W.M., Zhang W.Y., Kung M.H.W. Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis. J. Neuroimmunol. 2010, 227:178-184.
9. Collongues N., Marignier R., Zephir H., et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 2010, 74:736-742.
10. de Seze J., Stojkovic T., Ferriby D., Gauvrit J.Y., Montagne C., Mounier-Vehier F., Verier A., Pruvo J.P., Hache J.C., Vermersch P. Devic's neuromyelitis: clinical, laboratory, MRI and outcome profile. J. Neurol. Sci. 2002, 197:57-61.
11. Diamond B., Huerta P.T., Mina-Osorio P., Kowal C., Volpe B.T. Losing your nerves? Maybe it's the antibodies. Nat. Rev. Immunol. 2009, 9:449-456.
12. Ghezzi A., Bergamaschi R., Martinelli V., Trojano M., Tola M.R., Merelli E., Mancardi L., Gallo P., Filippi M., Zaffaroni M., Comi G. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J. Neurol. 2004, 251:47-52. Italian Devic's Study Group (IDESG).
13. Hinson S.R., Pittock S.J., Lucchinetti C.F., Roemer S.F., Fryer J.P., Kryzer T.J., Lennon V.A. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:1-11.
14. Hinson S.R., Roemer S.F., Lucchinetti C.F., Fryer J.P., Kryzer T.J., Chamberlain J.L., Howe C.L., Pittock S.J., Lennon V.A. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J. Exp. Med. 2008, 205(11):2473-2481.
15. Kim W., Park M.S., Lee S.H., Kim S.H., Jung I.J., et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult. Scler. 2010, 16(10):1229-1236.
16. Kinoshita M., Nakatsuji Y., Moriya M., Okuno T., Kumanogoh A., et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. NeuroReport 2009, 20:508-512.
17. Kinoshita M., Nakatsuji Y., Kimura T., Moriya M., Takata T., et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem. Biophys. Res. Commun. 2009, 386:623-627.
18. Kinoshita M., Nakatsuji Y., Kimura T., Moriya M., Takata T., et al. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem. Biophys. Res. Commun. 2010, 394:205-210.
19. Kugler S., Bocker K., Heusipp G., Greune L., Kim K. Pertussis toxin transiently affects barrier integrity, organelle organization and transcription of monocytes in a human brain microvascular endothelial cell barrier model. Cell. Microbiol. 2007, 6:619-632.
20. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
21. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to aquaporin-4 water channel. J. Exp. Med. 2005, 202:473-477.
22. Lucchinetti C.F., Mandler R.N., McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
23. Misu T., Fujihara K., Nakamura M., Murakami K., Endo M., Konno H., Itoyama Y. Loss of aquaporin-4 active in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J. Exp. Med. 2006, 209:269-275.
24. Pittock S.J., Lennon V.A., Krecke K., Wingerchuk D., Lucchinetti C.F., Weinshenker B.G. Brain abnormalities in neuromyelitis optica. Arch. Neurol. 2006, 63:390-396.
25. Pittock S.J., Weinshenker B.G., Lucchinetti C.F., Wingerchuk D., Corbay J.R., Lennon V.A. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch. Neurol. 2006, 63:964-968.
26. Popescu B.F., Lennon V.A., Parisi J.E., Howe C.L., Weigand S.D., Cabrera-Gómez J.A., Newell K., Mandler R.N., Pittock S.J., Weinshenker B.G., Lucchinetti C.F. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 2011, 76(14):1229-1237.
27. Raghavendra V., Tanga F.Y., DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 2004, 20:467-473.
28. Reiber H., Suckling A.J., Rumsby M.G. The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability. J. Neurol. Sci. 1984, 63(1):55-61.
29. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., Mandler R.N., Weinshenker B.G., Pittock S.J., Wingerchuk D.M., Lucchinetti C.F. Pattern specific loss of aquaporin-4 immunoreactivity distinguish neuromyelitis optica from multiple sclerosis. Brain 2007, 130(5):1194-1205.
30. Roth J., Harré E.M., Rummel C., Gerstberger R., Hübschle T. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front. Biosci. 2004, 9:290-300.
31. Saadoun S., Waters P., Bell B.A., Vincent A., Verkman A.S., Papadopoulos M.C. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis lesions in mice. Brain 2009, 133:349-361.
32. Sabater L., Giralt A., Boronat A., Hankiewicz K., Blanco Y., Llufriu S., Alberch J., Graus F., Saiz A. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J. Neuroimmunol. 2009, 215:31-35.
33. Sellner J., Hemmer B., Muhlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J. Autoimmun. 2010, 34:371-379.
34. Sinclair C., Kirk J., Herron B., Fitzgerald U., McQuaid S. Absence of aquaporin 4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. 2007, 113:187-194.
35. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., Watanabe S., Shiga Y., Kanaoka C., Fujimori J., Sato S., Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
36. Vincent T., Saikali P., Cayrol R., Roth A.D., Bar-Or A., Prat A., Antel J.P. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J. Immunol. 2008, 181:5730-5737.
37. Waters P., Jarius S., Littleton E., et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch. Neurol. 2008, 65:913-919.
38. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
39. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.